340 studies found for:    Open Studies | "Prednisone"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
Conditions: Granulomatosis With Polyangiitis;   Wegener Granulomatosis;   Vasculitis
Interventions: Drug: 5 mg prednisone;   Drug: 0 mg prednisone
2 Recruiting The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
Condition: Granulomatosis With Polyangiitis
Interventions: Drug: Prednisone 5 mg/day;   Drug: Prednisone 0 mg/day
3 Recruiting Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
Condition: Cellulitis
Interventions: Drug: Prednisone;   Drug: Placebo
4 Recruiting Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone
Condition: Multiple Myeloma
Interventions: Drug: velcade subcutaneous melphalan prednisone;   Drug: velcade cyclophosphamide prednisone;   Drug: velcade prednisone
5 Recruiting Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Condition: Thyroid Associated Opthalmopathies
Interventions: Drug: Prednisone+placebo of Doxycycline;   Drug: Doxycycline+placebo of Prednisone
6 Recruiting Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism)
Condition: Cholesterol Embolism Systemic
Interventions: Drug: prednisone;   Other: placebo
7 Recruiting Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
Condition: IgA Nephropathy
Interventions: Drug: prednisone plus cyclophosphamide;   Drug: Prednisone alone
8 Unknown  The Use of Oral Steroids in the Treatment of Cellulitis
Conditions: Cellulitis;   Erysipelas
Intervention: Drug: Prednisone
9 Recruiting A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)
Condition: Prostate Neoplasms
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone;   Other: Androgen deprivation therapy (ADT);   Drug: Abiraterone acetate Placebo;   Drug: Prednisone Placebo
10 Recruiting Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: Alisertib;   Drug: Abiraterone acetate;   Drug: Prednisone
11 Unknown  Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: prednisone, FK506, MMF;   Drug: prednisone
12 Not yet recruiting Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia;   Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia;   Untreated Adult Acute Lymphoblastic Leukemia
Interventions: Biological: blinatumomab;   Drug: prednisone;   Drug: vincristine sulfate;   Drug: methotrexate;   Drug: mercaptopurine;   Drug: dasatinib;   Other: laboratory biomarker analysis
13 Recruiting Short-term Prednisone to Treat STA Study(SPTSS)
Condition: Subacute Thyroiditis
Interventions: Drug: Prednisone 1 week;   Drug: Prednisone 6 weeks
14 Recruiting Pazopanib, Docetaxel, Prednisone Prostate
Condition: Prostate Cancer
Interventions: Drug: Pazopanib;   Drug: Docetaxel;   Drug: Prednisone;   Drug: Pegfilgrastim
15 Recruiting Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients
Condition: Prostate Cancer
Interventions: Drug: Docetaxel every 3 weeks + Prednisone;   Drug: Docetaxel weekly+ Prednisone
16 Recruiting Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: abiraterone acetate;   Drug: dasatinib;   Drug: prednisone
17 Recruiting Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: abiraterone acetate;   Drug: prednisone;   Drug: veliparib;   Other: laboratory biomarker analysis
18 Recruiting Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide, endoxan, prednisone;   Drug: lenalidomide, endoxan, prednisone
19 Recruiting Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
Condition: Chronic Rhinosinusitis Without Nasal Polyps
Interventions: Drug: Prednisone;   Drug: Topical mometasone
20 Recruiting Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery
Condition: Total Hip Replacement
Interventions: Drug: Prednisone;   Drug: Hydrocortisone;   Drug: Placebo (for Prednisone)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years